A Novel Pyruvate Kinase M2 Activator Compound that Suppresses Lung Cancer Cell Viability under Hypoxia - Kim, D.J., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Park, Y.S., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Kim, N.D., Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, Republic of Korea; Min, S.H., Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu, Republic of Korea; You, Y.M., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Jung, Y., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Koo, H., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Noh, H., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Kim, J.A., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Park, K.C., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea; Yeom, Y.I., Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea (Molecules and cells, 2015)
Keywords: ANOXIA; ANOXIE; Cell Hypoxia - physiology; Cell Line, Tumor; Cell Proliferation - physiology; Cell Survival - physiology; Humans; lung cancer,PA-12,PKM2 activator; Lung Neoplasms - enzymology; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Models, Molecular; Phosphorylation; Pyruvate Kinase - genetics; Pyruvate Kinase - metabolism; 생물학; lung cancer; PA-12; hypoxia; PKM2 activator